Gilmore O’Neill, M.B., M.M.Sc.

Gilmore O’Neill, M.B., M.M.Sc.

President and Chief Executive OfficeratEditas Medicine· In proxies 2022–2025

Pay in FY2025-54% from the year before · Editas Medicine stock +61.4% the same year

Gilmore O’Neill, M.B., M.M.Sc. was paid $2.4M in FY2025 (Dec), down 54%. Editas Medicine stock rose 61.4% that year.

Pay$100 in the stock at the end of FY21 → $8
Pay is from the Summary Compensation Table of each Editas Medicine proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Editas MedicinePublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -90%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?